EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

No impact of gluten-free diet on glycemia, growth, or quality of life in asymptomatic celiac disease with type 1 diabetes

Daniel I Weiman iD, Antoine B M Clarke, Keiran Pace, Esther Assor iD, Charlotte McDonald iD, Fred Saibil iD, Heather A Lochnan, Zubin Punthakee iD, Margaret A Marcon, Farid H Mahmud iD

Journal of the Endocrine Society · 02.11.2026 · 10 (12)

DOI: 10.1210/jendso/bvag222 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Endocrine Society, online erschienen am 17.11.2026. Verfasst von Daniel I Weiman und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario M5G 1X8, Canada. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Physicians’ Services Incorporated (PSI) Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Evidence is limited on longitudinal health outcomes with a gluten-free diet (GFD) in patients with type 1 diabetes (T1D) and asymptomatic celiac disease (CD) identified by screening.

Objectives

To investigate the impact of the GFD on glycemic management, anthropometrics, gastrointestinal symptoms, health-related quality of life (HRQoL), and nutritional intakes in patients with T1D and screen-detected CD.

Methods

Celiac Disease and Diabetes Longitudinal Follow-up and Evaluation Study (CD-LiFE) was a prospective follow-up study (NCT03122093) whereby 62 participants aged 8-45 years (77% adult, 23% pediatric) with T1D and screen-detected CD were evaluated annually over a 2-year study period.

Results

51.6% of participants were GFD-adherent (daily gluten intake < 10 mg) at study baseline. After 2 years, rates of GFD adherence increased (72.7%) with only 15.2% transitioning to a gluten-containing diet (GCD). No differences were seen in mean HbA1c levels between individuals on a GFD and GCD (Δ = 0.1%; 95% CI: −0.6 to 0.4; P = .613, weight (Δ = 0.2 kg/m2; 95% CI: −2.3 to 2.8; P = .848) or BMI among adults (Δ = −1.1 kg/m2; 95% CI: −0.4 to 0.6; P = .149) nor BMI Z scores among pediatric participants (Δ = 0.91; 95% CI: −0.34 to 2.16; P = .136), number of acute GI symptoms (IRR = 0.95; 95% CI: 0.6 to 1.5; P = .810) nor longitudinal differences in HRQoL with respect to generic (Δ = −0.4; 95% CI: −4.0 to 3.3; P = .840) nor diabetes-specific HRQoL (Δ = 1.5; 95% CI: −2.9 to 5.9; P = .505).

Conclusion

This 2-year follow-up study demonstrates adherence to a GFD does not impact glycemic control, anthropometrics, GI symptom development, or HRQoL in adult and pediatric patients with T1D and screen-detected CD.

Schlagwörter

Stichwörter der Autor:innen

celiac diseasegastrointestinal symptomsgluten-free dietglycemic controlhealth-related quality of lifetype 1 diabetes

Autor:innen und Institutionen

  • Division of Endocrinology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario M5G 1X8, Canada.
  • Division of Endocrinology and Metabolism, St. Joseph's Health Care, Western University, London, Ontario N6A 4V2, Canada.
  • Division of Gastroenterology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario M4N 3M5, Canada.
  • Division of Endocrinology and Metabolism, Department of Medicine, The Ottawa Hospital, University of Ottawa, Ottawa, Ontario K1H 7W9, Canada.
  • Department of Medicine, McMaster University, Hamilton, Ontario L8N 3Z5, Canada.
  • Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, The Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada.

ORCID-Profile: Daniel I Weiman, Esther Assor, Charlotte McDonald, Fred Saibil, Zubin Punthakee, Farid H Mahmud

Förderung

  • Physicians’ Services Incorporated (PSI) Foundation

Zitieren

APA

Weiman, D. I., Clarke, A. B. M., Pace, K., Assor, E., McDonald, C., Saibil, F., Lochnan, H. A., Punthakee, Z., Marcon, M. A., & Mahmud, F. H. (2026). No impact of gluten-free diet on glycemia, growth, or quality of life in asymptomatic celiac disease with type 1 diabetes. Journal of the Endocrine Society, 10(12). https://doi.org/10.1210/jendso/bvag222

Vancouver

Weiman DI, Clarke ABM, Pace K, Assor E, McDonald C, Saibil F, et al. No impact of gluten-free diet on glycemia, growth, or quality of life in asymptomatic celiac disease with type 1 diabetes. Journal of the Endocrine Society. 2026;10(12). doi:10.1210/jendso/bvag222

BibTeX
@article{Weiman2026,
  author = {Weiman, Daniel I and Clarke, Antoine B M and Pace, Keiran and Assor, Esther and McDonald, Charlotte and Saibil, Fred and Lochnan, Heather A and Punthakee, Zubin and Marcon, Margaret A and Mahmud, Farid H},
  title = {No impact of gluten-free diet on glycemia, growth, or quality of life in asymptomatic celiac disease with type 1 diabetes},
  journal = {Journal of the Endocrine Society},
  year = {2026},
  volume = {10},
  number = {12},
  doi = {10.1210/jendso/bvag222}
}
Kostenlos starten →